Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 Vaccination

Clin Nucl Med. 2022 Mar 1;47(3):e281-e283. doi: 10.1097/RLU.0000000000003980.

Abstract

A 67-year-old man with metastatic lung adenocarcinoma was initially treated with whole-brain radiotherapy for intracranial metastases, followed by chemotherapy and pembrolizumab. After completing 2 years of systemic therapy, the primary right lung lesion was biopsy-proven to have residual adenocarcinoma, which was then treated with radiation (6000 cGy in 15 fractions). Follow-up serial FDG PET/CT showed radiation fibrosis. Eighteen months after radiotherapy, the patient received 2 doses of an mRNA COVID-19 vaccine. FDG PET/CT performed 4 days following his second vaccine dose showed FDG-avid multistation lymphadenopathy and radiation recall pneumonitis, likely vaccination-induced and mimicking recurrent disease. This resolved spontaneously without therapy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • COVID-19 Vaccines*
  • COVID-19*
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Positron Emission Tomography Computed Tomography
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Fluorodeoxyglucose F18